Ultra Clean Holdings, Inc. — FY2015 Form 10-K
Business context and reporting period. The company designs and manufactures production tools, modules and subsystems, primarily for semiconductor-equipment OEMs, with additional exposure to medical, consumer and other markets. This annual report covers the fiscal year ended December 25, 2015; fourth-quarter figures are included below. In 2015, UCT acquired Marchi Thermal Systems, adding heaters and thermal-control products, and Miconex, adding precision plastic fabrication.
Financial performance and position
| Metric | FY2015 | FY2014 |
|---|---|---|
| Sales | $469.1 million | $514.0 million |
| Gross profit / margin | $71.0 million / 15.1% | $73.1 million / 14.2% |
| Operating income / margin | $5.8 million / 1.3% | $18.2 million / 3.5% |
| Income before taxes | $3.6 million | $16.3 million |
| Income tax provision | $14.3 million | $5.0 million |
| Net income (loss) | $(10.7) million | $11.4 million |
| Operating cash flow | $0.9 million | $30.4 million |
| Capital expenditures | $10.2 million | $5.3 million |
Fourth-quarter FY2015 sales were $103.4 million, gross profit was $13.3 million, and net loss was $15.8 million. The quarter’s loss included a substantial deferred-tax valuation allowance charge.
At year-end, cash and cash equivalents were $50.1 million, working capital was $125.4 million, total assets were $336.2 million, and stockholders’ equity was $200.9 million. Total debt was reported at $76.1 million; cash declined from $79.0 million in FY2014. Operating cash flow less capital expenditures was approximately negative $9.2 million.
Changes versus prior period
- Sales fell 8.7% year over year. Management attributed the decline principally to lower non-semiconductor sales, including the GT Advanced Technologies bankruptcy and insourcing by Intuitive Surgical; the latter reduced sales by approximately $26.9 million versus FY2014. Semiconductor sales rose approximately $10.0 million, partly reflecting the acquisitions.
- Gross margin improved to 15.1% from 14.2%, while gross profit dollars declined with lower sales. Management cited the absence of the prior-year GTAT-related cost and inventory charges and the acquired businesses as factors supporting the margin comparison.
- Operating income declined as operating expenses increased, including acquisition-related amortization and costs, higher research and development spending, and a $2.4 million payment to the former CEO upon retirement.
- The company recorded a $15.6 million charge from establishing a full valuation allowance on U.S. federal and state deferred tax assets. This drove the FY2015 tax provision above pretax income and resulted in a net loss.
- Cash from operations fell to $0.9 million from $30.4 million. Investing cash use rose to $55.2 million, primarily for the two acquisitions and capital expenditures; financing provided $25.4 million, including proceeds from new borrowings.
Outlook, risks and unusual items
- Management expected first-quarter FY2016 gross profit to be slightly higher than fourth-quarter FY2015, primarily on modestly higher expected sales. The filing provides no clear full-year revenue or earnings guidance.
- Management stated that available cash and operating cash flow were expected to cover debt service, working capital and technology-development needs for at least the next 12 months. This outlook depends on operating performance, industry conditions and continued covenant compliance.
- UCT’s business is cyclical and highly concentrated: Lam Research represented 50.6% of FY2015 sales and Applied Materials 26.4%, according to the customer-specific table. Customer orders generally lack minimum purchase commitments, and forecasts are nonbinding.
- The credit agreement includes a $40 million term loan and a $40 million revolver, restrictive covenants, mandatory excess-cash-flow prepayments and a requirement to maintain at least $35 million of cash at each quarter-end. UCT reported compliance at year-end. Total debt was $76.1 million, and foreign subsidiaries held $42.7 million of the $50.1 million cash balance; repatriation could create U.S. tax costs.
- Other material risks include supplier dependence and component shortages, pricing pressure, acquisition integration and goodwill impairment, foreign-operation and currency exposure, product liability, and manufacturing or IT disruptions. The company reported $40.3 million of inventory purchase commitments and $28.7 million of future minimum operating lease payments. It said ordinary-course legal proceedings were not expected to have a material adverse effect.
- Auditors issued an unmodified opinion on the financial statements and internal control over financial reporting. Management’s controls assessment excluded Marchi and Miconex, which were expected to be included in the FY2016 assessment.
Key investor verification points
- Reconcile customer concentration: the customer-specific table lists Lam and Applied at a combined 77.0% of FY2015 sales and ASM below 10%, while other filing sections state that the top three customers accounted for 84.3%.
- Reconcile geographic sales disclosures: management’s discussion gives U.S. sales of $307.4 million, while the geographic table reports $313.1 million for the United States.
- Assess the recurring earnings and cash-flow outlook after the U.S. deferred-tax valuation allowance, acquisition-related amortization, and weak FY2015 operating cash generation.
- Monitor debt, the $35 million minimum-cash covenant, required debt payments, and the availability of domestic liquidity given the concentration of cash in foreign subsidiaries.
- Track whether Marchi and Miconex deliver expected customer expansion and profitability, and whether the company can reduce dependence on its largest OEM customers.